Related Experiment Videos
Euglycemic insulin-induced hypotension in autonomic failure
R T Brown1, R J Polinsky, C E Baucom
1Clinical Neuropharmacology Section, National Institute of Neurological Diseases, Communicative Disorders, and Stroke, Bethesda, Maryland.
Clinical Neuropharmacology
|June 1, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Methylphenidate and hospitalized adolescents with conduct disorder: Dose effects on classroom behavior, academic performance, and impulsivity.
Journal of youth and adolescence·2013
The development of decoding of emotions in children with externalizing behavioral disturbances and their normally developing peers.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2003
Behavioral teratology/toxicology: how do we know what we know?
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2003
Self-assessment in clinical health psychology: a model for ethical expansion of practice.
Professional psychology, research and practice·2002
Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.
Clinical neuropharmacology·2026
Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.
Clinical neuropharmacology·2026
A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.
Clinical neuropharmacology·2026
Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.
Clinical neuropharmacology·2026
Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.
Clinical neuropharmacology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026